EP3840831A4 - Procédé et système permettant d'identifier des individus à haut risque de maladie inflammatoire intestinale, et méthode de traitement - Google Patents

Procédé et système permettant d'identifier des individus à haut risque de maladie inflammatoire intestinale, et méthode de traitement Download PDF

Info

Publication number
EP3840831A4
EP3840831A4 EP19852909.1A EP19852909A EP3840831A4 EP 3840831 A4 EP3840831 A4 EP 3840831A4 EP 19852909 A EP19852909 A EP 19852909A EP 3840831 A4 EP3840831 A4 EP 3840831A4
Authority
EP
European Patent Office
Prior art keywords
treatment
inflammatory bowel
bowel disease
high risk
identifying individuals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19852909.1A
Other languages
German (de)
English (en)
Other versions
EP3840831A1 (fr
Inventor
Bruce R. YACYSHYN
Mary E. Yacyshyn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP3840831A1 publication Critical patent/EP3840831A1/fr
Publication of EP3840831A4 publication Critical patent/EP3840831A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20Supervised data analysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/06Gastro-intestinal diseases
    • G01N2800/065Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Evolutionary Biology (AREA)
  • Pathology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Computation (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Software Systems (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Databases & Information Systems (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
EP19852909.1A 2018-08-21 2019-08-20 Procédé et système permettant d'identifier des individus à haut risque de maladie inflammatoire intestinale, et méthode de traitement Withdrawn EP3840831A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862720468P 2018-08-21 2018-08-21
PCT/US2019/047231 WO2020041287A1 (fr) 2018-08-21 2019-08-20 Procédé et système permettant d'identifier des individus à haut risque de maladie inflammatoire intestinale, et méthode de traitement

Publications (2)

Publication Number Publication Date
EP3840831A1 EP3840831A1 (fr) 2021-06-30
EP3840831A4 true EP3840831A4 (fr) 2022-05-11

Family

ID=69591310

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19852909.1A Withdrawn EP3840831A4 (fr) 2018-08-21 2019-08-20 Procédé et système permettant d'identifier des individus à haut risque de maladie inflammatoire intestinale, et méthode de traitement

Country Status (4)

Country Link
EP (1) EP3840831A4 (fr)
AU (1) AU2019325238A1 (fr)
CA (1) CA3108719A1 (fr)
WO (1) WO2020041287A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110045476A1 (en) * 2009-04-14 2011-02-24 Prometheus Laboratories Inc. Inflammatory bowel disease prognostics
US20120171672A1 (en) * 2009-04-14 2012-07-05 Prometheus Laboratories Inc. Inflammatory bowel disease prognostics

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833720B2 (en) * 2008-03-14 2010-11-16 Exagen Diagnostics, Inc. Biomarkers for inflammatory bowel disease and irritable bowel syndrome
US20130303391A1 (en) * 2010-09-14 2013-11-14 Oklahoma Medical Research Foundation Methods for diagnosis and prognosis of inflammatory bowel disease using cytokine profiles
JP2015502740A (ja) * 2011-10-21 2015-01-29 ネステク ソシエテ アノニム 炎症性腸疾患の診断を改善するための方法
WO2014182689A1 (fr) * 2013-05-06 2014-11-13 Yacyshyn Bruce R Procédé d'utilisation de biomarqueurs pour prédire une maladie intestinale inflammatoire
US10295527B2 (en) * 2016-03-14 2019-05-21 Bruce Yacyshyn Process and system for predicting responders and non-responders to mesalamine treatment of ulcerative colitis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110045476A1 (en) * 2009-04-14 2011-02-24 Prometheus Laboratories Inc. Inflammatory bowel disease prognostics
US20120171672A1 (en) * 2009-04-14 2012-07-05 Prometheus Laboratories Inc. Inflammatory bowel disease prognostics

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MORTENSEN JOACHIM HØG ET AL: "Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis", JOURNAL OF CROHN'S AND COLITIS, vol. 9, no. 10, 18 July 2015 (2015-07-18), NL, pages 863 - 872, XP055907377, ISSN: 1873-9946, Retrieved from the Internet <URL:https://watermark.silverchair.com/jjv123.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAuAwggLcBgkqhkiG9w0BBwagggLNMIICyQIBADCCAsIGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMzlRioibu2SG_AjSQAgEQgIICkychmHOXI4bIXNIYHuD5tuNT__UAlhuhR8PZjY7gI7o-RWwR4EpdLYCym14YZC_DExTXJtjw0prrXSo88LeV4tO1llfYC> DOI: 10.1093/ecco-jcc/jjv123 *

Also Published As

Publication number Publication date
AU2019325238A1 (en) 2021-03-18
CA3108719A1 (fr) 2020-02-27
WO2020041287A1 (fr) 2020-02-27
EP3840831A1 (fr) 2021-06-30

Similar Documents

Publication Publication Date Title
EP3735695A4 (fr) Système et procédé de prise en charge de patient
IL276893A (en) Systems and methods for detecting residual disease
EP3806737A4 (fr) Appareil et procédé pour la détection d&#39;événements physiologiques
GB201804895D0 (en) System and method for identifying at least one association of entity
EP3352670B8 (fr) Procédé et système permettant d&#39;évaluer la cicatrisation d&#39;un tissu
GB202101021D0 (en) Automated modulars system and method for production of biopolymers
EP4024228A4 (fr) Système et procédé de calcul de caractéristiques de lot et en temps réel
EP3888539A4 (fr) Procédé et système de facilitation d&#39;inspection
IL278958A (en) An image-based method and system for studying relational systems
IL290438A (en) A system and method for determining the onset of a disease and its progression
EP4085312A4 (fr) Système et procédé pour identifier des éléments comparables
EP3762921A4 (fr) Système et procédé de documentation clinique automatisés
IL285788A (en) System and method for improving biological tissue imaging
IL276243A (en) A system for characterizing tissues and a method related thereto
EP3765025A4 (fr) Méthode de traitement de l&#39;asthme ou d&#39;une maladie allergique
EP3762928A4 (fr) Système et procédé de documentation clinique automatisée
EP3897994B8 (fr) Procédé et agencement pour un traitement d&#39;eau de traitement
EP3842977A4 (fr) Système et procédé d&#39;aide à l&#39;utilisation d&#39;un objet d&#39;utilisation
EP3840831A4 (fr) Procédé et système permettant d&#39;identifier des individus à haut risque de maladie inflammatoire intestinale, et méthode de traitement
EP3860440B8 (fr) Procédé et système d&#39;évaluation de mouvements humains
EP3727422A4 (fr) Système et procédé pour le traitement d&#39;une maladie à l&#39;aide d&#39;un système de protéines modifiées hyperspécifique
EP3850567A4 (fr) Système et procédé de mise en oeuvre d&#39;écosystèmes de traitement de transactions
HK40118740A (en) Methods for identifying and treating diseases
AU2018901296A0 (en) System and method for inhibiting blood coagulation
IL317115A (en) Methods for identifying and treating diseases

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210317

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220411

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/68 20060101ALI20220405BHEP

Ipc: G01N 33/53 20060101ALI20220405BHEP

Ipc: G01N 33/48 20060101ALI20220405BHEP

Ipc: C12Q 1/68 20180101ALI20220405BHEP

Ipc: A61P 1/00 20060101AFI20220405BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230207

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20240103

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20240504